Boston Scientific stock has experienced a significant decline, with some outlets suggesting it may be a bargain after a slump. However, there is uncertainty about whether the stock will rebound or is a value trap. Some analysts appear to be optimistic about the company's fundamentals and potential for growth, while others have noted a recent losing streak for the stock.